The effect of number of histogram events on reproducibility and variation of flow cytometric proliferation measurement

American Journal of Clinical Pathology

Volumn 105, Issue 6, 1996, Pages 696-704

  Brown, Ronald D ^a   Linden, Michael D ^a   Mackowiak, Pat ^a   Kubus, James J ^a   Zarbo, Richard J ^a   Rabinovitch, Peter S ^b  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

DNA analysis; Flow cytometry; S phase fraction

Indexed keywords

PROPIDIUM IODIDE;

ARTICLE; CELL CYCLE S PHASE; CELL PROLIFERATION; DIAGNOSTIC ACCURACY; DNA DETERMINATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REPRODUCIBILITY;

EID: 0029938585     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.6.696     Document Type: Article

References (24)

1. Merkel DE, McGuire WL. Ploidy, proliferative activity and prognosis: DNA flow cytometry of solid tumors. Cancer 1990;65: 1194-1205.
2. Merkel DE, Winchester DJ, Golschmidt RA, August CZ, Wruck DM, Rademaker AW. DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancer. Cancer 1993;72:1926-1932.
3. Bagwell CB. Theoretical aspects of flow cytometry data analysis. In: Bauer KD, Duque RE, Shankey TV, eds. Clinical Flow Cytometry. Principles and Application. Baltimore: Williams and Wilkins, 1993, pp 41-61.
4. Rabinovitch PS. Practical considerations for DNA content and cell cycle analysis. In: Bauer KD, Duque RE, Shankey TV, eds. Clinical Flow Cytometry: Principles and Application. Baltimore: Williams and Wilkins, 1993, pp 117-142.
5. Harlow SP, Eriksen BL, Poggensee L, et al. Prognostic implications of proliferative activity and DNA aneuploidy in Astler Coller state C colonic adenocarcinoma. Cancer Res 1991;51:2403-2409.
6. Frierson JF. Ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast. Am J Surg Pathol 1991;15:358-367.
7. Hatschek T, Fagerberg G, Sullivan S, Carstensen J, Grontoft O, Nordenskjold B. Cytometric characterization and clinical course of breast cancer diagnosed in a population-based screening program. Cancer 1989;64:1074-1081.
8. Strang P, Stendahl U, Bergstrom R, Frankendal B, Tribukait B. Prognostic flow cytometric information in cervical squamous cell carcinoma: A multivariate analysis of 307 patients. Gynecol Oncol 1991;43:3-8.
9. Bauer KD, Lincoln ST, Vera-Roman JM, et al. Prognostic implications of proliferative activity and DNA aneuploidy in colonic adenocarcinomas. Lab Invest 1987;57:329-335.
10. Clark GM, Dressier LG, Owens MA, Pounds G, Oldaker T, McGuire WL. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 1989;320:627-633.
11. Zarbo RJ, Linden MD. DNA analysis of gastrointestinal and genitourinary tract neoplasms. In: Keren DF, Hanson H, Hurtubise P, eds. Flow Cytometry in Clinical Diagnosis. Chicago: ASCP Press, 1993, pp 470-540.
12. Crissman JD, Zarbo RJ, Niebylski CD, Corbett T, Weaver D. Flow cytometric DNA analysis of colon adenocarcinomas: A comparative study of preparatory techniques. Mod Pathol 1988;1: 198-204.
13. Silverstrini R. SICCAB Group quality control of cell kinetic determinations. Quality control for evaluation of the S-phase fraction by flow cytometry: A multicentric study. Cytometry 1994;18: 11-16.
14. Wersto RP, Liblit RL, Deitch D, Koss LG. Variability in DNA measurements in multiple tumor samples of human colonic carcinoma. Cancer 1991;67:106-115.
15. Wersto RP, Liblit RL, Koss LG. Flow cytometric DNA analysis of solid tumors: A review of the interpretation of DNA histograms. Hum Pathol 1991;22:1085-1098.
16. Shankey TV, Rabinovitch PS, Bagwell B, et al. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993;14: 472-477.
17. Baisch H, Beck HP, Christensen IJ, et al. A comparison of mathematical methods for the analysis of DNA histograms obtained by flow cytometry. Cell Tissue Kinetics 1982;15:235-249.
18. Zarbo RJ, Visscher DW, Crissman JD. Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen. Analyt Quant Cytol Histol 1989;11:391-402.
19. Zarbo RJ. Quality control issues and technical considerations in flow cytometric DNA and cell cycle analysis of solid tumors. In: Keren DF, Hanson H, Hurtubise P, eds. Flow Cytometry in Clinical Diagnosis. Chicago: ASCP Press, 1993, pp 425-469.
20. Rabinovitch PS. Multicycle/Multicycle AV Users Manual. San Diego: Phoenix Flow Systems, 1993.
21. Brown RD, Zarbo RJ, Linden MD, et al. Two-color multiparametric method for flow cytometric DNA analysis: Standardization of spectral compensation. Am J Clin Pathol 1994;101:630-637.
22. Zarbo RJ, Brown RD, Linden MD, Torres FX, Nakhleh RE, Schultz DS. Rapid (one-shot) staining method for two-color multiparametric DNA flow cytometric analysis of carcinomas using staining for cytokeratin and leukocyte common antigen. Am J Clin Pathol 1994;101:638-642.
23. Linden MD, Ma CM, Kubus J, Brown RD, Zarbo RJ. Ki-67 and proliferating cell nuclear antigen tumor proliferative indices in DNA diploid colorectal adenocarcinomas. Am J Clin Pathol 1993;100:206-212.
24. Visscher DW, Wykes S, Zarbo RJ, Crissman JD. Multiparametric evaluation of flow cytometric synthesis phase fraction determination in dual-labelled breast carcinomas. Analyt Quant Cytol Histol 1991;13:246-252.